TY - JOUR
T1 - Adrenergic receptor-mediated modulation of striatal firing patterns
AU - Ohta, Hiroyuki
AU - Kohno, Yu
AU - Arake, Masashi
AU - Tamura, Risa
AU - Yukawa, Suguru
AU - Sato, Yoshiaki
AU - Morimoto, Yuji
AU - Nishida, Yasuhiro
AU - Yawo, Hiromu
N1 - Funding Information:
We are grateful to S. Kanda, Drs. K. Ooyo and Y. Yamaguchi for great technical assistance, and to D. A. Tyurmin for language assistance. This work was supported by MEXT / JSPS KAKENHI Grant Number 24700200 , a grant for Specific Research from National Defense Medical College , Defense Medicine Propulsion Research of the Ministry of Defense, Japan , the Cooperative Research Project Program of RIEC , Tohoku University , the Research Foundation for Opto-Science and Technology , Hamamatsu, Japan and CREST, Japan Science and Technology Agency .
Publisher Copyright:
© 2016 Elsevier Ireland Ltd and Japan Neuroscience Society
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Although noradrenaline and adrenaline are some of the most important neurotransmitters in the central nervous system, the effects of noradrenergic/adrenergic modulation on the striatum have not been determined. In order to explore the effects of adrenergic receptor (AR) agonists on the striatal firing patterns, we used optogenetic methods which can induce continuous firings. We employed transgenic rats expressing channelrhodopsin-2 (ChR2) in neurons. The medium spiny neuron showed a slow rising depolarization during the 1-s long optogenetic striatal photostimulation and a residual potential with 8.6-s half-life decay after the photostimulation. As a result of the residual potential, five repetitive 1-sec long photostimulations with 20-s onset intervals cumulatively increased the number of spikes. This ‘firing increment’, possibly relating to the timing control function of the striatum, was used to evaluate the AR modulation. The β-AR agonist isoproterenol decreased the firing increment between the 1st and 5th stimulation cycles, while the α1-AR agonist phenylephrine enhanced the firing increment. Isoproterenol and adrenaline increased the early phase (0–0.5 s of the photostimulation) firing response. This adrenergic modulation was inhibited by the β-antagonist propranolol. Conversely, phenylephrine and noradrenaline reduced the early phase response. β-ARs and α1-ARs work in opposition controlling the striatal firing initiation and the firing increment.
AB - Although noradrenaline and adrenaline are some of the most important neurotransmitters in the central nervous system, the effects of noradrenergic/adrenergic modulation on the striatum have not been determined. In order to explore the effects of adrenergic receptor (AR) agonists on the striatal firing patterns, we used optogenetic methods which can induce continuous firings. We employed transgenic rats expressing channelrhodopsin-2 (ChR2) in neurons. The medium spiny neuron showed a slow rising depolarization during the 1-s long optogenetic striatal photostimulation and a residual potential with 8.6-s half-life decay after the photostimulation. As a result of the residual potential, five repetitive 1-sec long photostimulations with 20-s onset intervals cumulatively increased the number of spikes. This ‘firing increment’, possibly relating to the timing control function of the striatum, was used to evaluate the AR modulation. The β-AR agonist isoproterenol decreased the firing increment between the 1st and 5th stimulation cycles, while the α1-AR agonist phenylephrine enhanced the firing increment. Isoproterenol and adrenaline increased the early phase (0–0.5 s of the photostimulation) firing response. This adrenergic modulation was inhibited by the β-antagonist propranolol. Conversely, phenylephrine and noradrenaline reduced the early phase response. β-ARs and α1-ARs work in opposition controlling the striatal firing initiation and the firing increment.
KW - Alpha1 adrenergic receptor
KW - Beta adrenergic receptor
KW - Noradrenaline
KW - Striatum
UR - http://www.scopus.com/inward/record.url?scp=84977648345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84977648345&partnerID=8YFLogxK
U2 - 10.1016/j.neures.2016.05.004
DO - 10.1016/j.neures.2016.05.004
M3 - Article
C2 - 27287299
AN - SCOPUS:84977648345
VL - 112
SP - 47
EP - 56
JO - Neuroscience Research
JF - Neuroscience Research
SN - 0168-0102
ER -